Prior to using Pfizer to make Copaxone...MNTA had a different manafacturer for the product...i dont recall where China or Singapore? How difficult would be for them to restart that relationship and production line?
I believe you are confusing the API product and the Fill/Finish operation. I kind of remember that it was WuXi (China) who made one of the API's.
Market Data 
Markets 
AI
